Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Knowing when long term capital gains apply is vital for optimizing your investment outcomes. Understand your tax benefits to enhance your strategy.
27,839 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Bitcoin spent the week wavering around the 80K level, briefly spiking above, then slipping as inflation data and regu...
Late Saturday, gunfire near the White House prompted a rapid security response. Authorities reported no injuries, whi...
A Capitol Hill hearing pits growth-focused remedies against traditional funding gaps for Social Security, with the na...
A large insider sale at Relay Therapeutics coincides with a dramatic stock rally. This article breaks down what the r...
Bloom Energy faces a bearish price prediction as momentum cools and AI-driven demand faces headwinds, suggesting sign...
Credo Technology Group has surged about 90% year-to-date, fueling debate on whether the rally can sustain amid new AI...
As 2026 unfolds with higher volatility, analysts flag a trio of ETFs that may help retirees balance income and risk. ...
What if you could stack two reliable income engines at once? This guide shows how blending rental properties with pri...
As energy markets shift, investors must decide between EQT's pure-play gas model and Occidental's global oil mix. Thi...
Citi lifts its TMUS price target to $225, citing robust cash flow and a big buyback. The call comes as investors weig...
Verizon Communications stock soaring in 2026 has investors debating its next move. This guide breaks down the drivers...